Company news

OraSure Technologies, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference

June 16, 2021

OraSure and the Will Rodgers Liver Health Foundation to Heighten Awareness Around the Importance of Hepatitis C Testing

June 13, 2021

OraSure Technologies Receives Three Emergency Use Authorizations for its COVID-19 Rapid Antigen Tests for Non-Prescription (OTC), Professional and Prescription Use

June 6, 2021

OraSure Technologies to Present at the Jefferies Virtual Healthcare Conference

May 27, 2021

OraSure Technologies to Present at the UBS Global Healthcare Virtual Conference

May 17, 2021

OraSure Technologies Appoints Scott Gleason As Senior Vice President Investor Relations and Corporate Communications

May 16, 2021

OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 18, 2021

May 11, 2021

OraSure Technologies, Inc. Announces First Quarter 2021 Financial Results and Provides COVID-19 Update

May 4, 2021

OraSure Technologies Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization

March 29, 2021

OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update

February 28, 2021

OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing

January 27, 2021

OraSure’s OMNIgene®·ORAL Saliva Collection Kit Selected by Chronomics for Use in UK Government “Test to Release for International Travel” COVID-19 Testing Program

January 25, 2021

OraSure Technologies Announces 2021 Annual Meeting Date

January 7, 2021

OraSure’s OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test

December 22, 2020

OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 Antibody Test

December 20, 2020

OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments

November 3, 2020

OraSure’s DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect®·RNA Saliva Collection Device for SARS CoV-2

November 2, 2020

OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5: 00 p.m. ET

October 20, 2020

OraSure’s OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2

October 18, 2020

OraSure Technologies, Inc. Announces 2020 Second Quarter Financial Results and Update on COVID-19 Testing Programs

August 4, 2020

OraSure’s OMNIgene®·ORAL Device Included in EUA Granted to Clinical Reference Laboratory for Self-Collected SARS-CoV-2 Saliva Test

July 30, 2020

OraSure Technologies to Hold Second Quarter 2020 Earnings Conference Call on August 5th, 2020

July 21, 2020

OraSure Technologies Receives BARDA Funding for Coronavirus Antibody ELISA Using Oral Fluid Samples

June 9, 2020

OraSure’s Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test

June 7, 2020

OraSure Technologies, Inc. Announces Exercise of Option to Purchase Additional Shares of Common Stock

June 2, 2020

OraSure Technologies, Inc. Prices Underwritten Offering of Common Stock

June 1, 2020

OraSure Technologies, Inc. Announces Proposed Public Offering of Common Stock

May 31, 2020

OraSure Technologies, Inc. Announces Purchase of UrSure, Inc.

May 28, 2020

OraSure Technologies Appoints Lelio Marmora to Board of Directors

May 28, 2020

OraSure’s OMNIgene®·ORAL Kit Included in EUA Granted to P23 Labs for At-Home Collection of Saliva Samples for SARS-CoV-2 Test

May 21, 2020

OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 19, 2020

May 13, 2020

OraSure Technologies, Inc. Consolidates Microbiome Services Subsidiaries

May 11, 2020

OraSure Announces 2020 First Quarter Financial Results and Provides COVID-19 Update

May 5, 2020

OraSure Technologies Appoints Lisa Nibauer as Infectious Disease Business Unit Lead

May 4, 2020

OraSure Technologies Appoints David J. Shulkin, M.D. to Board of Directors

April 7, 2020

OraSure Technologies Receives BARDA Contract for Rapid Oral Fluid Pan-SARS-Coronavirus In-home Self-test

April 5, 2020

OraSure Announces 2019 Full Year and Fourth Quarter Financial Results

February 18, 2020

OraSure Technologies Announces 2020 Annual Meeting Date

December 16, 2019

OraSure Technologies, Inc. Announces Purchase of Diversigen

November 5, 2019

OraSure Announces 2019 Third Quarter Financial Results

November 5, 2019

OraSure Technologies Announces Support for New Federal Oral Fluid Drug Testing Guidelines

October 27, 2019

← Newer news releases

Calls

The 5 newest of 16 calls. Every call is listed under its year.

Decks

The 5 newest of 24 decks. Every deck is listed under its year.